Drug information for CESAMET

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
CAPSULE; ORAL 1MG Prescription  (Reference Drug) NABILONE nabilone MEDA PHARMS 18677
2008-12-10 Letter

2006-05-18 Letter

2006-05-16 Label

Drug Adverse Effects information for CESAMET

Role code Indications Reaction # Reports
C ANXIETY DRUG DEPENDENCE 3
C ANXIETY DRUG WITHDRAWAL SYNDROME 3
C ANXIETY SUBSTANCE ABUSE 3
C ARTHRALGIA DRUG DEPENDENCE 18
C ARTHRALGIA DRUG WITHDRAWAL SYNDROME 18
C ARTHRALGIA SUBSTANCE ABUSE 18
C ASTHMA DRUG DEPENDENCE 1
C ASTHMA DRUG WITHDRAWAL SYNDROME 1
C ASTHMA SUBSTANCE ABUSE 1
C BREAKTHROUGH PAIN DRUG DEPENDENCE 5
C BREAKTHROUGH PAIN DRUG WITHDRAWAL SYNDROME 5
C BREAKTHROUGH PAIN SUBSTANCE ABUSE 5
C CONTRACEPTION FISTULA 1
C CONTRACEPTION INCISION SITE INFECTION 1
C CONTRACEPTION INTESTINAL OBSTRUCTION 1
C CONTRACEPTION INTESTINAL STENOSIS 1
C CONTRACEPTION NEURALGIA 1
C CROHN'S DISEASE FISTULA 3
C CROHN'S DISEASE INCISION SITE INFECTION 3
C CROHN'S DISEASE INTESTINAL OBSTRUCTION 3
C CROHN'S DISEASE INTESTINAL STENOSIS 3
C CROHN'S DISEASE NEURALGIA 3
C DEPRESSION DRUG DEPENDENCE 2
C DEPRESSION DRUG WITHDRAWAL SYNDROME 2
C DEPRESSION FISTULA 2
C DEPRESSION INCISION SITE INFECTION 2
C DEPRESSION INTESTINAL OBSTRUCTION 2
C DEPRESSION INTESTINAL STENOSIS 2
C DEPRESSION NEURALGIA 2
C DEPRESSION SUBSTANCE ABUSE 2
C INSOMNIA DRUG DEPENDENCE 2
C INSOMNIA DRUG WITHDRAWAL SYNDROME 2
C INSOMNIA SUBSTANCE ABUSE 2
C MENOPAUSE ALANINE AMINOTRANSFERASE INCREASED 1
C MENOPAUSE ANAEMIA POSTOPERATIVE 1
C MENOPAUSE ANGIOPLASTY 1
C MENOPAUSE ASPARTATE AMINOTRANSFERASE INCREASED 1
C MENOPAUSE ASTHENIA 1
C MENOPAUSE BACK PAIN 1
C MENOPAUSE BLOOD ALKALINE PHOSPHATASE INCREASED 1
C MENOPAUSE BONE DISORDER 1
C MENOPAUSE DIARRHOEA 1
C MENOPAUSE GAMMA-GLUTAMYLTRANSFERASE INCREASED 1
C MENOPAUSE GASTROOESOPHAGEAL REFLUX DISEASE 1
C MENOPAUSE GINGIVAL DISORDER 1
C MENOPAUSE HEPATIC STEATOSIS 1
C MENOPAUSE INFLUENZA LIKE ILLNESS 1
C MENOPAUSE INJECTION SITE ERYTHEMA 1
C MENOPAUSE INJECTION SITE PRURITUS 1
C MENOPAUSE NAUSEA 1
C MENOPAUSE OEDEMA PERIPHERAL 1
C MENOPAUSE POST PROCEDURAL HAEMATOMA 1
C MENOPAUSE SNEEZING 1
C MENOPAUSE ULCER 1
C MENOPAUSE VOMITING 1
C MENOPAUSE WEIGHT INCREASED 1
C MULTIPLE SCLEROSIS ALANINE AMINOTRANSFERASE INCREASED 1
C MULTIPLE SCLEROSIS ANAEMIA POSTOPERATIVE 1
C MULTIPLE SCLEROSIS ANGIOPLASTY 1
C MULTIPLE SCLEROSIS ASPARTATE AMINOTRANSFERASE INCREASED 1
C MULTIPLE SCLEROSIS ASTHENIA 1
C MULTIPLE SCLEROSIS BACK PAIN 1
C MULTIPLE SCLEROSIS BLOOD ALKALINE PHOSPHATASE INCREASED 1
C MULTIPLE SCLEROSIS BONE DISORDER 1
C MULTIPLE SCLEROSIS DIARRHOEA 1
C MULTIPLE SCLEROSIS GAMMA-GLUTAMYLTRANSFERASE INCREASED 1
C MULTIPLE SCLEROSIS GASTROOESOPHAGEAL REFLUX DISEASE 1
C MULTIPLE SCLEROSIS GINGIVAL DISORDER 1
C MULTIPLE SCLEROSIS HEPATIC STEATOSIS 1
C MULTIPLE SCLEROSIS INFLUENZA LIKE ILLNESS 1
C MULTIPLE SCLEROSIS INJECTION SITE ERYTHEMA 1
C MULTIPLE SCLEROSIS INJECTION SITE PRURITUS 1
C MULTIPLE SCLEROSIS NAUSEA 1
C MULTIPLE SCLEROSIS OEDEMA PERIPHERAL 1
C MULTIPLE SCLEROSIS POST PROCEDURAL HAEMATOMA 1
C MULTIPLE SCLEROSIS SNEEZING 1
C MULTIPLE SCLEROSIS ULCER 1
C MULTIPLE SCLEROSIS VOMITING 1
C MULTIPLE SCLEROSIS WEIGHT INCREASED 1
C PRODUCT USED FOR UNKNOWN INDICATION DRUG DEPENDENCE 19
C PRODUCT USED FOR UNKNOWN INDICATION DRUG WITHDRAWAL SYNDROME 19
C PRODUCT USED FOR UNKNOWN INDICATION SUBSTANCE ABUSE 19
C PROPHYLAXIS FISTULA 2
C PROPHYLAXIS INCISION SITE INFECTION 2
C PROPHYLAXIS INTESTINAL OBSTRUCTION 2
C PROPHYLAXIS INTESTINAL STENOSIS 2
C PROPHYLAXIS NEURALGIA 2
C PSORIATIC ARTHROPATHY ARTHRITIS 1
C PSORIATIC ARTHROPATHY WEIGHT INCREASED 1
C THYROID DISORDER FISTULA 1
C THYROID DISORDER INCISION SITE INFECTION 1
C THYROID DISORDER INTESTINAL OBSTRUCTION 1
C THYROID DISORDER INTESTINAL STENOSIS 1
C THYROID DISORDER NEURALGIA 1
C TOOTHACHE DRUG DEPENDENCE 1
C TOOTHACHE DRUG WITHDRAWAL SYNDROME 1
C TOOTHACHE SUBSTANCE ABUSE 1
Ads by Google